Global drugmakers have started launching generic or low-priced version of popular medicines and have slashed prices of their existing products to increase market share in India, taking on local competitors in their own game.

French drugmaker Sanofi Aventis has launched a range of generic drugs, some at half the price of competing brands of local companies, while Japan